by
Brendon Nafziger, DOTmed News Associate Editor | June 23, 2011
Still River Systems Inc. said Wednesday it signed a long-term licensing agreement with the Massachusetts Institute of Technology for technologies to be used with its small-footprint, single-room proton therapy system.
The agreement covers superconducting accelerator technologies developed at MIT's Plasma Science and Fusion Center in collaboration with Still River Systems, the Littleton, Mass.-based company said. Terms of the deal weren't disclosed.
Still River's first synchrotron-based proton therapy unit, called the Monarch 250, is being installed at the Barnes-Jewish Hospital, a 1,228-bed facility in St. Louis. It's expected to start treating patients next year.
Ad Statistics
Times Displayed: 7647
Times Visited: 24 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
Early published figures put the total cost of equipment and construction of Still River's project at around $20 million, well shy of the $120 million to $300 million price tag of most U.S. proton therapy centers.
